K. Young

Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET

G. Savage, P. Nathan, K. Wesnes, 2008, Psychopharmacology.

Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.

A. Scott, M. Morris, Jason S. Lewis, 2016, Journal of labelled compounds & radiopharmaceuticals.

Automated radiosynthesis of [68Ga]Ga‐PSMA‐11 and [177Lu]Lu‐PSMA‐617 on the iPHASE MultiSyn module for clinical applications

A. Scott, G. Chan, U. Ackermann, 2020, Journal of labelled compounds & radiopharmaceuticals.

Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients

C. Rowe, R. Mulligan, V. Villemagne, 2018, BMJ Open.

11C labelling of AG957—a potential tyrphostin radiotracer for PET

A. Scott, H. Tochon-Danguy, U. Ackermann, 2002 .

Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale

Vincent Doré, Christopher C Rowe, Kenneth Young, 2016, The Journal of Nuclear Medicine.

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease

C. Rowe, C. Masters, H. Tochon-Danguy, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with 18F-AV133 and PET

C. Rowe, R. Mulligan, Gareth Jones, 2017, The Journal of Nuclear Medicine.